Lacidipine
- Level
- Commodity
- Parent
- 51433900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51433923This classification denotes a calcium channel blocker with the molecular formula C26H33NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 260080034N, chemically known as 1h-imidazole-5-methanol, 2-butyl-4-chloro-1-((2-(1h-tetrazol-5-yl)(1,1- biphenyl)-4-yl)methyl)- but generally known as lacidipine, which bears US NIH Compound Identifier 3961. European Medicines Agency schedules Lacidipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08383MIG. The term LACIDIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules lacidipine in its Anatomical Therapeutic Chemical (ATC) Classification. LACIDIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lacidipine under HS 29333999 and SITC 51574. As of Q4 2014, LACIDIPINE remains the US FDA Preferred Term for this commodity. Lacidipine bears US NLM identifiers UMLS ID C0064568 and NCI Concept Code C80881. SMILES: Clc1nc(n(Cc2ccc(cc2)c2c(cccc2)c2n[nH]nn2)c1CO)CCCC.
Same parent
Under 51433900 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.